Rankings
▼
Calendar
PCRX FY 2013 Earnings — Pacira BioSciences, Inc. Revenue & Financial Results | Market Cap Arena
PCRX
Pacira BioSciences, Inc.
$982M
FY 2013 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$86M
+118.9% YoY
Gross Profit
$31M
36.0% margin
Operating Income
-$53M
-62.3% margin
Net Income
-$64M
-74.7% margin
EPS (Diluted)
$-1.93
Cash Flow
Operating Cash Flow
-$43M
Free Cash Flow
-$56M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$170M
Total Liabilities
$129M
Stockholders' Equity
$41M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$86M
$39M
+118.9%
Gross Profit
$31M
$7M
+343.2%
Operating Income
-$53M
-$49M
-8.1%
Net Income
-$64M
-$52M
-22.2%
← FY 2012
All Quarters
FY 2014 →